Boston Scientific Wins FDA Approval For Quadripolar Leads, Initiates Trial To Expand MRI Labeling

Boston Scientific FDAapproval for the ACUITYX4 Quadripolar Left Ventricular (LV) leads. The FDA approval of the quadripolar leads, the wires that connect cardiac resynchronization therapy (CRT) devices to the heart, marks the first time the company will offer a full X4 CRT system – both the device and the leads – to the U.S. market.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news